VRIDAPA S 5/50 TABLET
Generic Salt Composition: Dapagliflozin 5mg + Sitagliptin 50mg
Price: ₹50 MRP: ₹152.81
Save up to 67% compared to branded medicines.
Top Brand Substitutes & Equivalents
Forxiga, Jardiance, Januvia, Dapa-Sitagliptin, Dapagliflozin + Sitagliptin, Glynase, Gluconorm, Zita-D, Dapa-S, Sitagliptin/Dapagliflozin, Dapa-Sit, Dapa-V, Dapa-Combo, Dapa-Sitagliptin Tablets, Dapa-Sitagliptin 5/50, Dapa-Sitagliptin Generic, Dapa-Sitagliptin Brand, Dapa-Sitagliptin Combo, Dapa-Sitagliptin 5mg/50mg, Dapagliflozin Sun Pharma, Sun Pharma Dapagliflozin, Dapagliflozin Cipla, Cipla Dapagliflozin, Dapagliflozin Dr Reddys, Dr Reddys Dapagliflozin, Dapagliflozin Lupin, Lupin Dapagliflozin, Dapagliflozin Torrent, Torrent Dapagliflozin, Dapagliflozin Alkem
Product Overview & Uses
VRIDAPA S 5/50 TABLET is a potent oral antidiabetic medication designed for patients who require dual-action therapy to achieve target HbA1c levels. Classified within the Diabetes Care category, this tablet utilizes the synergistic effects of Dapagliflozin (5mg) and Sitagliptin (50mg). Dapagliflozin works by inhibiting the SGLT2 protein in the kidneys, which prevents the reabsorption of glucose, thereby promoting its excretion via urine. Simultaneously, Sitagliptin acts as a DPP-4 inhibitor, which increases the levels of incretin hormones that stimulate insulin release and decrease glucagon levels. By integrating VRIDAPA S 5/50 TABLET into a comprehensive Diabetes Care regimen, patients can effectively lower their blood glucose levels, reduce the risk of cardiovascular complications, and improve overall metabolic health when combined with appropriate diet and exercise.